Overview
Allos, an Oxford, UK-based company utilizing causal AI for clinical outcomes, raised $5 million in seed funding. The round was led by Oxford Science Enterprises with participation from Habico Invest, the family office of Danish pharmaceutical group Orifarm, and the University of California accelerator Berkeley SkyDeck. The funds will support the company's expansion.
Products
Loading...
Recent Deals
Investors: Oxford Science Enterprises, Habico Invest, University of California accelerator Berkeley SkyDeck
Allos, an Oxford, UK-based company utilizing causal AI for clinical outcomes, raised $5 million in seed funding. The round was led by Oxford Science Enterprises with participation from Habico Invest, the family office of Danish pharmaceutical group Orifarm, and the University of California accelerator Berkeley SkyDeck. The funds will support the company's expansion.